Ahmet Sezer
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
- Oncology 25
- Cancer Immunotherapy and Biomarkers 12
- Inflammatory Biomarkers in Disease Prognosis 4
- Cancer Diagnosis and Treatment 3
-
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- Özgür Özyılkan (22 shared papers)Hüseyin Mertsoylu (17 shared papers)Ali Ayberk Beşen (16 shared papers)Fatih Köse (17 shared papers)Ahmet Taner Sümbül (16 shared papers)Erkan Topkan (6 shared papers)Uğur Selek (6 shared papers)Ahmet Küçük (5 shared papers)
- Journals
- Annals of Oncology (6 papers)Journal of Clinical Oncology (5 papers)Medical Oncology (4 papers)Journal of Thoracic Oncology (4 papers)Journal of Oncology (2 papers)
- Partner nations
- TürkiyeUnited StatesUkraine
In The Last Decade
Ahmet Sezer
45 papers receiving 405 citations
Peers
Comparison fields: 5 of 52
- Otorhinolaryngology 35
- Oncology 192
- Pulmonary and Respiratory Medicine 102
- Neurology 28
- Pathology and Forensic Medicine 32
Countries citing papers authored by Ahmet Sezer
This map shows the geographic impact of Ahmet Sezer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Sezer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Sezer more than expected).
Fields of papers citing papers by Ahmet Sezer
This network shows the impact of papers produced by Ahmet Sezer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Sezer. The network helps show where Ahmet Sezer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ahmet Sezer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 48 | |
| 2 | 2020 | 28 | |
| 3 | 2019 | 28 | |
| 4 | 2010 | 26 | |
| 5 | 2014 | 22 | |
| 6 | 2020 | 20 | |
| 7 | Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experience. | 2011 | 19 |
| 8 | 2009 | 17 | |
| 9 | 2011 | 14 | |
| 10 | 2019 | 12 | |
| 11 | 2018 | 12 | |
| 12 | Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis. | 2018 | 10 |
| 13 | 2019 | 10 | |
| 14 | 2022 | 10 | |
| 15 | The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer. | 2014 | 9 |
| 16 | 2019 | 9 | |
| 17 | 2021 | 8 | |
| 18 | 2012 | 8 | |
| 19 | 2020 | 7 | |
| 20 | 2014 | 7 |
About Ahmet Sezer
Ahmet Sezer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Surgery, having authored 48 papers that have together received 410 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer Diagnosis and Treatment (3 papers) and Head and Neck Cancer Studies (2 papers). The work is most often cited by research in Otorhinolaryngology (35 citations), Oncology (192 citations), Pulmonary and Respiratory Medicine (102 citations), Neurology (28 citations) and Pathology and Forensic Medicine (32 citations). Ahmet Sezer has collaborated with scholars based in Türkiye, United States and Ukraine. Frequent co-authors include Özgür Özyılkan, Hüseyin Mertsoylu, Ali Ayberk Beşen, Fatih Köse, Ahmet Taner Sümbül, Erkan Topkan, Uğur Selek, Ahmet Küçük, Yurday Özdemir and Umut Dişel. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Medical Oncology, Journal of Thoracic Oncology and Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.